You are here


Genomics researchers partner with industry to further innovation in health, agriculture and environment sectors

Friday, December 1, 2017

Government of Canada and partners invest more than $24 million in genomics research projects to improve cancer treatments and reduce greenhouse gas emissions.

When scientists work with their counterparts in industry, they’re able to invent life-saving therapies and clean technologies that improve the lives of Canadians. That’s why the Government of Canada is committed to supporting collaborative research led by scientists across the country.

Canada a leader in global coalition to accelerate genomic data sharing that will benefit Canadian patients

Tuesday, October 17, 2017

Genomics is underpinning a global revolution in healthcare, from a generalized approach, to one that is individually tailored based on a patient’s genetic profile – an approach known as precision medicine. Rapid advances in the field – and the opportunities for discovery and new therapeutics – make it imperative to develop international policies and standards to enable the responsible, voluntary, and secure sharing of genomic data.

Genome Canada welcomes Canada’s new Chief Science Advisor

Wednesday, September 27, 2017

Genome Canada congratulates Dr. Mona Nemer on her appointment as Canada’s new Chief Science Advisor and applauds the Government of Canada on its excellent choice.

Dr. Nemer’s deep commitment to Canada’s research community, both as a renowned scientist and as an esteemed university vice-president of research, are widely recognized and celebrated here in Canada and abroad. 

New Vice-President, Public Affairs and Communications at Genome Canada

Thursday, September 7, 2017

Genome Canada is delighted to welcome Rob Annan as Vice-President, Public Affairs and Communications, effective September 11, 2017.

In this role, Dr. Annan will drive an overarching strategy that promotes the value and potential of genomics in Canada to Genome Canada’s major stakeholders, while raising the public profile of Genome Canada both nationally and internationally.

Stem-cell researchers solve mystery of relapse in acute myeloid leukemia

Wednesday, June 28, 2017

Leukemia researchers led by Dr. John Dick have traced the origins of relapse in acute myeloid leukemia (AML) to rare therapy-resistant leukemia stem cells that are already present at diagnosis and before chemotherapy begins.

They have also identified two distinct stem-cell like populations from which relapse can arise in different patients in this aggressive cancer that they previously showed starts in blood stem cells in the bone marrow.